Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome

@article{Crowley2008VariationIT,
  title={Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome},
  author={J. Crowley and R. Lipsky and I. Lucki and W. Berrettini},
  journal={Psychiatric Genetics},
  year={2008},
  volume={18},
  pages={248-251}
}
  • J. Crowley, R. Lipsky, +1 author W. Berrettini
  • Published 2008
  • Biology, Medicine
  • Psychiatric Genetics
  • The identification of genetic variants regulating antidepressant response would allow for more individualized, rational, and successful drug treatments. We previously identified a region of mouse chromosome 19 that strongly influences citalopram response in an antidepressant model, the tail suspension test. By virtue of their location in this loci, expression in brain, and involvement in monoamine neurotransmission, we nominated SLC18A2 (encoding vesicular monoamine transporter 2, a.k.a. VMAT2… CONTINUE READING
    13 Citations
    Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson’s disease
    • 49
    Pharmacogenetics of Antidepressants
    • 85
    • PDF
    Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research
    • C. Fabbri, Giulia di Girolamo, A. Serretti
    • Medicine
    • American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
    • 2013
    • 66
    Pharmacogenetics of Antidepressant Drugs: An Update
    • 2
    • Highly Influenced
    • PDF
    Blood-based biomarkers predicting response to antidepressants
    • 10

    References

    SHOWING 1-9 OF 9 REFERENCES
    Analysis of Association Between the Serotonin Transporter and Antidepressant Response in a Large Clinical Sample
    • 108
    Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
    • 405
    Pharmacogenomic Evaluation of the Antidepressant Citalopram in the Mouse Tail Suspension Test
    • 49
    • PDF
    The functional significance of genetic variation within the beta-adrenoceptor.
    • 29
    Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.
    • 1,505
    • Highly Influential
    • PDF
    Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
    • 2,602
    • PDF
    Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
    • 782
    QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies
    • 738
    • Highly Influential
    STAR*D Study Team
    • Am J Psychiatry
    • 2006